[vc_row full_width=“stretch_row_content_no_spaces“ el_class=“procedure-hero“][vc_column][vc_single_image image=“2837″ img_size=“full“ alignment=“center“ el_class=“no-mb infinite-image desktop-image“][vc_single_image image=“3344″ img_size=“full“ alignment=“center“ el_class=“no-mb infinite-image mobile-image“][vc_custom_heading text=“Der Aufsichtsrat“ font_container=“tag:h1|text_align:left|color:%23ffffff|line_height:1″ use_theme_fonts=“yes“][vc_raw_html el_class=“no-mb“]JTNDaDYlMjBjbGFzcyUzRCUyMmhlYWQtYnJlYWRjcnVtYiUyMiUzRSUzQ2ElMjBocmVmJTNEJTIyJTJGZGUlMkYlMjIlM0VTdGFydHNlaXRlJTNDJTJGYSUzRSUyMCUyRiUyMERlciUyMEF1ZnNpY2h0c3JhdCUzQyUyRmg2JTNF[\/vc_raw_html][\/vc_column][\/vc_row][vc_row full_width=“stretch_row“ css=“.vc_custom_1639056624265{padding-top: 10px !important;padding-bottom: 50px !important;background-color: #ffffff !important;}“][vc_column][vc_column_text el_class=“directors“]<\/p>\n
Ron Labrum ist ein erfahrener Vertriebsh\u00e4ndler und Leiter in den Bereichen Gesundheitswesen und Medizinprodukte. Er begann seine berufliche Laufbahn bei American Hospital Supply und war mehr als 25 Jahre bei Baxter International, Allegiance Healthcare und Cardinal Health t\u00e4tig. Bis zur kurzem f\u00fchrte er Fenwal, Inc., einem von Private-Equity-Unternehmen finanzierten Spinout des auf Technologie f\u00fcr Blutuntersuchungen spezialisierten Gesch\u00e4ftsbereichs von Baxter, als CEO. In Laufe seiner Karriere hielt Ron eine Reihe von F\u00fchrungsrollen im Vertriebs-, Betriebs- und Fertigungsbereich inne und war federf\u00fchrend an der Durchf\u00fchrung und Integration zahlreicher Fusionen und Akquisitionen beteiligt. Ron ist derzeit Mitglied des Vorstand von Ortho-Clinical Diagnostics, Wright Medical, Aptalis und Suture Express.<\/p>\n
Jim Hollingshead verf\u00fcgt \u00fcber mehr als drei Jahrzehnte globale F\u00fchrungserfahrung in der Medizintechnik und den Life Sciences. Seine Karriere ist gepr\u00e4gt von der Einf\u00fchrung marktpr\u00e4gender Produkte sowie dem Aufbau und der Skalierung wachstumsstarker Plattformen. Vor seinem Eintritt bei BVI f\u00fchrte er zweimal wegweisende Unternehmen durch eine disziplinierte Strategie und konsequente Umsetzung zu f\u00fchrenden Marktpositionen.<\/p>\n
Als President und CEO der Insulet Corporation (2022\u20132025), nach seiner T\u00e4tigkeit als unabh\u00e4ngiges Vorstandsmitglied, verantwortete Jim die Einf\u00fchrung bahnbrechender Technologien, die Wettbewerber \u00fcberholten und Insulet als Marktf\u00fchrer etablierten. Zuvor war er bei ResMed in mehreren leitenden Funktionen t\u00e4tig, unter anderem als President des Gesch\u00e4ftsbereichs Sleep and Respiratory Care und als Chief Strategy Officer. Dort leitete er die Konzeption und Einf\u00fchrung cloudbasierter L\u00f6sungen, die die Branchenlandschaft nachhaltig ver\u00e4nderten und die weltweite Einf\u00fchrung beschleunigten.<\/p>\n
Mark Blumenkranz ist der HJ Smead Professor Emeritus in der Abteilung f\u00fcr Augenheilkunde an der Stanford University, Managing Director von Lagunita Biosciences sowie Chairman und CEO von Kedalion Therapeutics. Er ist ein international anerkannter Spezialist f\u00fcr vitreo-retinale Chirurgie und kann auf wichtige Beitr\u00e4ge in den Bereichen f\u00fcr neue Lasersysteme, neuartige Pharmazeutika f\u00fcr Makulaerkrankungen, okulare Gentherapie sowie die Entwicklung augen\u00e4rztlicher Telemedizin und Technologie verweisen. Vor der \u00dcbernahme durch Allergan war er als Direktor bei Oculex Pharmaceuticals t\u00e4tig. Er war ein Gr\u00fcnder und Direktor von Peak Surgical, einem von Medtronic \u00fcbernommenen Unternehmen, und von Optimedica, einem von AMO \u00fcbernommenen Unternehmen, das nun zu Johnson and Johnson geh\u00f6rt. Mark war Mitgr\u00fcnder und der erste Vorstandsvorsitzende von Adverum Biotechnologies sowie Mitgr\u00fcnder und Direktor von Oculeve, einem ebenfalls von Allergan \u00fcbernommenen Unternehmen. Er ist au\u00dferdem ein Mitgr\u00fcnder und Direktor von Verana Health sowie Vorstandsmitglied von One Medical und Iveric Bio.<\/p>\n
Kendall Garrison ist ein Partner bei dem in San Francisco ans\u00e4ssigen Unternehmen TPG, wo er sich auf Investitionen im Gesundheitssektor konzentriert. Vor Aufnahme seiner T\u00e4tigkeit bei TPG arbeitete Kendall in der Investment-Banking-Sparte von Goldman, Sachs & Co. Kendall geh\u00f6rte au\u00dferdem dem Vorstand von Exactech, Kelsey-Seybold, Kindred at Home und Kindred Healthcare an und war an den Investitionen von TPG in Immucor, Surgical Care Affiliates und Sabre Holdings beteiligt.<\/p>\n
Cindy Lucchese ist Chief Administrative Officer und Chief Financial Officer of Penske Entertainment, einem auf Motorsport-Wettbewerbe und Unterhaltung spezialisierten Unternehmen. Davor war sie als Senior Vice President und Chief Financial Officer von Hillenbrand, Inc. t\u00e4tig, einem b\u00f6rsennotierten Unternehmen mit zahlreichen Marken, die Kunden in einer Reihe von Branchen auf der ganzen Welt bedienen. Cindy verf\u00fcgt \u00fcber umfassende Erfahrung mit Medizinprodukt- und Life-Science-Unternehmen, einschlie\u00dflich Guidant, Thoratec und Eli Lilly. Sie ist Mitglied des Vorstands von Inari Medical, Intersect ENT, Inc. und Hanger, Inc.<\/p>\n
Dana Mead, Jr., President und CEO von HeartFlow, verf\u00fcgt \u00fcber mehr als 30\u00a0Jahre Erfahrung in der Zusammenarbeit mit im gesamten Spektrum des Gesundheitswesens t\u00e4tigen Unternehmen. Er konzentriert sich auf die Identifizierung von aufkommender Medizintechnik, die Entwicklung neuer Therapien, die Erschlie\u00dfung neuer M\u00e4rkte und den Aufbau von Managementteams der Spitzenklasse. Zuvor war Dana als President und CEO von BVI t\u00e4tig, und davor fungierte er als ein Partner von Kleiner Perkins Caufield & Byers sowie als President von Guidant Vascular Intervention. Im Laufe seiner Karriere hielt er au\u00dferdem Vertriebs- und Marketingrollen bei Allergan und Johnson & Johnson inne. Derzeit ist Dana Mitglied des Vorstands von Inspire Medical, Intersect ENT und Pulmonx.<\/p>\n
Marc Nolet de Brauwere verf\u00fcgt \u00fcber mehr als 30\u00a0Jahre Erfahrung in Produktentwicklung, Gesch\u00e4ftswachstum und Betriebsf\u00fchrung in der Branche f\u00fcr ophtalmologische Produkte, insbesondere im Bereich von Intraokularlinsen (IOLs) f\u00fcr die Kataraktchirurgie. Er erwarb PhysIOL\u00ae\u00a0im Jahr\u00a01997 und leitete die Organisation in einer Zeit von branchenf\u00fchrendem Wachstum und best\u00e4ndig innovativen Produktentwicklungen und -einf\u00fchrungen, einschlie\u00dflich der weltweit ersten trifokalen IOL.<\/p>\n
Jeff Rhodes ist ein Partner in der Niederlassung von TPG in San Francisco, wo er als einer der Leiter der Gruppe f\u00fcr das Gesundheitswesen und der Investitionsaktivit\u00e4ten des Unternehmens in den Sektoren Gesundheitsdienstleistungen, Pharmazie und Medizinprodukte t\u00e4tig ist. Vor Aufnahme seiner T\u00e4tigkeit bei TPG arbeitete Jeff bei McKinsey & Company und dem Startup-Softwareunternehmen Article27 LTD. Jeff geh\u00f6rte au\u00dferdem den Vorst\u00e4nden von Immucor, Kelsey Seybold Clinic, Kindred Healthcare, Kindred at Home, Lifestance und WellSky an.<\/p>\n
John Schilling ist Co-Managing Partner von TPG Capital, leitet das Operations-Team von TPG Capital, co-leitet das Healthcare-Team von TPG Capital und f\u00fchrt die Einf\u00fchrung der Life Science Innovations-Franchise von TPG an. John war Mitglied des Vorstands oder hatte F\u00fchrungsrollen in vielen Investitionen von TPG, darunter Adare Pharmaceuticals, Aptalis, AskBio, BVI, Confluent, EnvisionRx, Kelsey Seybold, OneOncology, Par Pharmaceutical und Surescripts. Vor seinem Eintritt bei TPG im Jahr 2011 leitete John den Vertrieb und das Marketing f\u00fcr das US-amerikanische Pharma-Gesch\u00e4ft bei Abbott und war Partner bei McKinsey & Company.<\/p>\n
John erhielt seinen Bachelor-Abschluss in Biomedizinischer und Elektrotechnik von der Duke University, einen Master-Abschluss in Biomedizinischer Technik von der Johns Hopkins University, wo er ein Bozzelli Scholar war, und einen M.D. von der Universit\u00e4t Chicago, wo er den Joseph A. Capps Award als herausragendster Student in klinischer Medizin erhielt. Anschlie\u00dfend absolvierte John seine chirurgische Facharztausbildung an der Johns Hopkins University.<\/p>\n
Todd Smith ist President, CEO und Direktor von Assertio. Zuvor fungierte er bis zur Fusion des Unternehmens mit Assertio als CEO von Zyla Life Sciences sowie als CEO von Iroko Pharmaceuticals. Er hielt au\u00dferdem f\u00fchrende Rollen bei der Ophthotech Corporation und bei Horizon Therapeutics inne. Todd verf\u00fcgt \u00fcber mehr als 25\u00a0Jahre Erfahrung als F\u00fchrungskraft in Pharma-, Medizinprodukt- und Biotechnologie-Unternehmen. Er kann auf eine lange Erfolgsgeschichte beim Aufbau von Unternehmen und der Erzielung von Spitzenleistungen in der gewerblichen und gesch\u00e4ftlichen Entwicklung verweisen, in deren Rahmen er einen best\u00e4ndigen Schwerpunkt auf den Zugang von Patienten zu einem differenzierten Produktportfolio legte. Todd fungiert derzeit als Vorstandsmitglied von Vault Nano.[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"
[vc_row full_width=“stretch_row_content_no_spaces“ el_class=“procedure-hero“][vc_column][vc_single_image image=“2837″ img_size=“full“ alignment=“center“ el_class=“no-mb infinite-image desktop-image“][vc_single_image image=“3344″ img_size=“full“ alignment=“center“ el_class=“no-mb infinite-image mobile-image“][vc_custom_heading text=“Der Aufsichtsrat“ font_container=“tag:h1|text_align:left|color:%23ffffff|line_height:1″ use_theme_fonts=“yes“][vc_raw_html el_class=“no-mb“]JTNDaDYlMjBjbGFzcyUzRCUyMmhlYWQtYnJlYWRjcnVtYiUyMiUzRSUzQ2ElMjBocmVmJTNEJTIyJTJGZGUlMkYlMjIlM0VTdGFydHNlaXRlJTNDJTJGYSUzRSUyMCUyRiUyMERlciUyMEF1ZnNpY2h0c3JhdCUzQyUyRmg2JTNF[\/vc_raw_html][\/vc_column][\/vc_row][vc_row full_width=“stretch_row“ css=“.vc_custom_1639056624265{padding-top: 10px !important;padding-bottom: 50px !important;background-color: #ffffff !important;}“][vc_column][vc_column_text el_class=“directors“] Ronald Labrum, Chairman Ron Labrum ist ein erfahrener Vertriebsh\u00e4ndler und Leiter in den Bereichen Gesundheitswesen und Medizinprodukte. Er begann seine berufliche Laufbahn bei American Hospital Supply […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"fullwidth.php","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"class_list":["post-1591","page","type-page","status-publish","hentry"],"acf":[],"rankMath":{"parentDomain":"www.bvimedical.com","noFollowDomains":[],"noFollowExcludeDomains":[],"noFollowExternalLinks":false,"featuredImageNotice":"Das angezeigte Beitragsbild sollte mindestens 200x200 px gro\u00df sein, damit Facebook und andere Social-Media-Websites es \u00fcbernehmen.","pluginReviewed":false,"postSettings":{"linkSuggestions":true,"useFocusKeyword":false},"frontEndScore":false,"postName":"der-aufsichtsrat","permalinkFormat":"https:\/\/www.bvimedical.com\/de\/%pagename%\/","showLockModifiedDate":true,"assessor":{"focusKeywordLink":"https:\/\/www.bvimedical.com\/de\/wp-admin\/edit.php?focus_keyword=%focus_keyword%&post_type=%post_type%","hasTOCPlugin":false,"primaryTaxonomy":false,"serpData":{"title":"BVI Medical\u00a0\u2013\u00a0Aufsichtsrat","description":"BVI Aufsichtsrat: R.\u00a0Labrum, S.\u00a0Korangy, M. S.\u00a0Blumenkranz, K.\u00a0Garrison, C.\u00a0Lucchese, D.\u00a0G.\u00a0Mead, M.\u00a0N.\u00a0de\u00a0Brauwere, J.\u00a0Rhodes, J.\u00a0Schilling, T.\u00a0Smith","focusKeywords":"Aufsichtsrat","pillarContent":false,"canonicalUrl":"","breadcrumbTitle":"","advancedRobots":[],"facebookTitle":"","facebookDescription":"","facebookImage":"","facebookImageID":"","facebookHasOverlay":false,"facebookImageOverlay":"","facebookAuthor":"","twitterCardType":"","twitterUseFacebook":true,"twitterTitle":"","twitterDescription":"","twitterImage":"","twitterImageID":"","twitterHasOverlay":false,"twitterImageOverlay":"","twitterPlayerUrl":"","twitterPlayerSize":"","twitterPlayerStream":"","twitterPlayerStreamCtype":"","twitterAppDescription":"","twitterAppIphoneName":"","twitterAppIphoneID":"","twitterAppIphoneUrl":"","twitterAppIpadName":"","twitterAppIpadID":"","twitterAppIpadUrl":"","twitterAppGoogleplayName":"","twitterAppGoogleplayID":"","twitterAppGoogleplayUrl":"","twitterAppCountry":"","robots":{"index":true},"twitterAuthor":"Benutzername","primaryTerm":0,"authorName":"gds","titleTemplate":"%title% %sep% %sitename%","descriptionTemplate":"%excerpt%","showScoreFrontend":true,"lockModifiedDate":false},"powerWords":["abgelenkt","abgesturzt","absolut","abstossend","aburd","abweisen","adaquat","aggressiv","ahnungslos","akkurat","alarmierend","alarmiert","albtraum","all-inclusive","allererste","allererster","allererstes","alleswisser","am schlechtesten","am wichtigsten","angewidert","angriff","angsteinflossend","angstlich","animiert","ankundigung","anonym","anpassbar","anspruchslos","anstossig","antagonistisch","apokalypse","applaus","argumentativ","arm","armageddon","arrogant","atemberaubend","attacke","attraktiv","aufdeckend","aufgebracht","aufgedeckt","aufgeregt","aufheiternd","aufregend","aufregende","aufregenden","aufregung","aufstachelnd","aufstandisch","aufsteigend","auftreibend","augenoffnend","ausgelassen","ausgeruht","ausgespielt","ausgewahlt","ausgewuhlt","ausnutzen","aussergewohnlich","autark","authentisch","autoritat","backdoor","badass","beangstigend","bedenklich","bedingungslos","bedrohen","bedroht","beforderung","befreit","befriedigend","befriedigt","begehren","begeistern","begeistert","begeisterung","beherzt","behind the scenes","beichte","beleidigung","belohnung","bemerkenswert","beneiden","bequem","beruhmt","beschadigen","beschamend","beschmutzt","beschuldigen","beschutzen","besitz","bessesen","bestatigen","bestatigt","beste","bestimmt","bestrafen","betrug","betrugen","bewahrt","bewiesen","bewiesenermassen","bewusst","bezahlbar","bezaubernd","bizarre","bleich","blendend","blut","blutbad","blutig","bombe","bonanza","bonus","bosartig","bose","boshaft","brilliant","brodelnd","brutal","budget","bullshit","bully","bunt","bunte","bunten","case study","cash","challenge","challgene","chaos","cheat-sheet","clever","content","cool","courage","dankbar","daruber redet keiner","deadline","definitiv","dekadent","demoralisierend","demut","desillusioniert","detailiert","diagnose","die wahrheit","direkt","disastros","discount","dokument","dollar","dominieren","doppelt","download","dreckig","dreifach","dreistigkeit","dringend","dringlichkeit","dumm","dummkopf","dummlich","durchbruch","duselig","dynamik","echt","effektiv","effizient","ehrlich","eier","eifersuchtig","eifrig","eindeutig","eindrucksvoll","eine stufe besser","einfach","einfachheit","einfallsreich","eingebildet","eingeschrankt","eingesperrt","einmalig","einsam","eintauchen","einzigartig","eisern","eliminieren","elite","empathie","empfehle","empfehlen","endeffekt","energie","energisch","enorm","entdecken","entfesselt","entfremdet","enthullen","enthullung","enthusiastisch","entmachtet","entsetzlich","entspannt","entzuckend","entzunden","epidemisch","episch","erbarmlich","erfolg","erfolgreich","erfolgsbilanz","erfreut","erfullen","erfullt","ergebnisse","ergreifen","erhaben","erheben","erhohen","erledigt","ermachtigt","ermudet","ernmutigt","ernsthaft","erobern","erroten","errungenschaft","erschaffen","erschrocken","ersehnen","ersparnisse","erstattbar","erstatten","erstaunlich","erste","ertrinken","essentiell","ethisch","euphorisch","exakt","exklusiv","exklusivitat","exkuisit","experte","explodieren","explosiv","exposed","extrem","exzellent","fahig","fahigkeiten","fail","falle","fantasie","fantastischen","farbenfroh","farbenfrohe","faszinierend","faszinierende","faul","faux pas","faux","fehler","feindselig","feldstudie","fesselnd","festlich","festmahl","festplatte","final","flirt","fluchtling","flussig","fokus","fokussiert","folter","formel","frech","freebie","frei","freiheit","freudig","friedlich","frohlich","frohlichkeit","frustriert","fundamental","fur immer","furchtbar","furchtlos","gangster","garantiert","geblendet","geehrt","gefahr","gefahrlich","gefangen","gefangnis","gefeuert","gegensatzlich","gehassig","geheimnis","geheimnisse","geil","geisseln","geist","geistesgestort","gelassen","geld zuruck","geld","genial","gepackt","gerade angekommen","gerissen","geschenk","geschmuggelt","geschutzt","gestandnis","gestandnisse","gestopft","gestresst","gesucht","gesund","getauscht","getestet","getotet","gewaltig","gewalttatig","gewidmet","gewinnspiel","gier","gierig","gift","giftig","gigantisch","giveaway","glamourose","glanzend","glaube","glaubwurdig","gleichmassig","glittering","glitzernde","gluckselig","golden","grandios","grandiose","grandiosen","grandioses","grauenhaft","grausamkeit","grinsen","groesste","gross","grossartig","grossartig","grossartige","grossartigen","grossartiger","grossartiges","grosse","grossen","grosste","grosszugig","grotesk","grube","grundlegend","gruselig","gunstig","hack","hamisch","hammer","handelsgeheimnis","hartnackig","hass","heilig","heimlich","heisshunger","heisshungrig","heiter","held","hell","herablassend","herausfordernd","herausforderung","herausvorderung","herrlichen","herrschend","hervorragend","herz","herzbrechend","herzerwahrmend","heute","hightech","hilflosigkeit","hilfreich","hilfsbereit","himmlisch","hinterhaltig","hoax","hocheffektiv","hochnasig","hochste","hoffnung","hoffnungsvoll","holle","holocaust","horror","how to","humor","hungrige","hurrikan","hypnotisch","hypnotisierend","idiot","idiotisch","illegal","immer","informativ","inhalt","inkompetent","innovativ","insider","inspirierend","inspiriert","intelligent","intensiv","interessant","interessante","invasion","investment","ist da","jackpot","jederzeit kundigen","jetzt","jubilant","jumpstart","jung","kadaver","kampf","katapult","katastrophe","kaufen","kein risiko","keine verpflichtung","kickstart","kindisch","kitschig","klaglich","klar","knast","kollabieren","kollosal","komfortabel","komisch","kompetitiv","komplett","kompromiss","komsich","konstruktiv","kontrollierend","kontrollverlust","kooperativ","kopie","korrupt","kostenlos","kraftlos","kraftvoll","krankhaft","kreativ","kreative","kriese","kritisch","kruppel","lachen","lacherlich","lahm","last minute","lauernd","lebendig","lebenslanglich","lecken","lecker","legendar","legitim","leiche","leicht","leiden","leider","leise","letzte chance","letzte","leuchtend","liberal","licht","liebe","liebenswurdig","liebevoll","life-changing","limitiert","lohnend","loser","losung","lugen","lugend","lukrativ","lust","lustig","lustige","lustigsten","luxorios","magisch","mainstream","mammut","manipulativ","massiv","masterclass","meditierend","meiseter","meistverkauft","meltdown","millionen","mind-blowing","minderwertig","minimalist","missbrauch","misstrauisch","mittelmassig","mittig","modern","moderne","moglichkeiten","monetarisieren","monumental","mord","motiviert","muhelos","muhevoll","mull","mut","mutig","nachmachen","nachteile","nackt","nagel","naiv","natural","nazi","neid","nervos","neu","niedertrachtig","niemals","notfall","notiert","nutzlich","nutzlos","offensichtlich","offiziel","offnen","ohne hintergedanken","ok","okay","okonomisch","on-demand","opfer","optimistisch","overnight","packend","panik","panzer","paralisiert","pas","passioniert","pause","payback","peinlich","perfekt","perplex","perskeptive","pessimistisch","pfund","piranha","pleite","plotzlich","pochend","polarisierend","popular","portfolio","praktisch","preis","prestige","privat","privatsphare","priviligiert","problem","produktiv","professionell","profit","profitabel","provokativ","provozierend","prozess","psychologisch","qual","qualen","qualitat","rabatt","rache","rachsuchtig","raffiniert","rasend","rat","rau","recherche","reduziert","reflektieren","regeln","reich","reiche","reichtum","relaxed","report","responsive","revolutionar","riesig","risiko","riskant","riskieren","rotzfrech","rowdy","ruckrat","ruckschlag","rucksichtlos","ruhig","ruiniert","sabotiert","sadistisch","sale","sarkastisch","scam","schabig","schadigend","schadlich","schamlos","schatz","schicksal","schlachten","schlafen","schlag","schlau","schlimm","schmerzhaft","schmerzlos","schmuggel","schnell","schnellstart","schokierend","schonheit","schrecklich","schreien","schritt fur schritt","schuld","schuldlos","schwach","schwarm","schwarzmarkt","schwerkraft","schwinden","sechsstellig","sehenswerte","selbsthass","selten","sensationell","sex","sexy","sicher","sicherheit","sicherlich","sieg","sill","simpel","sinnlich","sinnlos","skandal","skandalos","skill","sklave","sneak-peek","snob","sofort gespart","sofort","sollte","sonnig","sonnige","sonnigen","sorgen","sorgfaltig","sorglos","spannend","sparen","sparsam","spass","spassig","spektakular","speziell","spielen","spoiler","spontan","spotlight","stabil","stark","start","stoisch","stolz","stop","strahlend","strangulieren","strategie","studien","stumperhaft","stur","sunden","sundigend","super","superb","survival","tapfer","tauschend","teaser","technologie","terror","terrorist","teuer","tief","tiefgreifend","tierisch","tod","todlich","toll","tolle","toller","tortur","tot","tote","toten","totend","toxisch","tragisch","tragodie","transfomieren","transparenz","trauma","traumatisiert","traurigkeit","trend","tricks","trigger","triumpf","trocken","trotz","trugerisch","tweaks","tyrann","ubel","uberfordert","uberkommen","uberleben","uberlegen","uberraschend","uberrascht","uberraschung","uberwaltigend","uberwinden","ultimativ","umfassend","umstritten","umwerfend","unatorisiert","unaufhaltbar","unausgelasted","unbedacht","unbeliebt","unbeschwert","unbewusst","undercover","undokumentiert","unehrlich","unentschlossen","unerwartet","unfahig","ungeduldig","ungedult","ungehort","ungemutlich","ungerechtfertigt","ungesehen","ungetrubt","ungewohnlich","ungezogen","unglaublich","unglaubliches","uninteressiert","unkontrollierbar","unkonventionell","unlimitiert","unpenetrierbar","unschuldig","unsicher","unstabil","unter verschluss","untergrund","unterhaltsam","unterstutz","unterstutzend","unubertroffen","unvergesslich","unverneinbar","unvoreingenommen","unwiderstehlich","unwirtlich","unzensiert","unzuverlassig","up-selling","vaporisieren","verangstigt","verantwortlich","verargert","verarscht","verbessert","verbluffend","verblufft","verboten","verbreiten","verdachtig","verdammt","verdeckt","vereinfacht","verfuhrend","vergebend","vergessen","vergleich","verhauen","verifizieren","verkommen","verlegen","verletzbar","verletzt","verlockend","verloren","vermasselt","vermeiden","vermogen","vernichten","vernichtend","vernunftig","veroffentlichung","verpassen","verraterisch","verruckt","versagen","verschwitzt","versichert","verspielt","versprechend","versteckt","vertrauenswurdig","vertraulich","vertraumt","verurteilend","verwunderlich","verwundet","verzaubernd","verzweifelt","vierfach","vogelfrei","vollig","vollstandig","vorsicht","vorstellungskraft","vorteil","wachstum","wagemutig","wahnsinn","wahnsinnig","wahrhaftig","wahrheit","wahrheitsgemass","wahrscheinlich","warnung","was dir keiner sagt","wehleidig","welt","wenig bekannt","wert","wertvoll","wichtig","widerlich","wiedererkannt","wild","wilde","wilden","willensstarke","wirr","wohltatigkeit","wortlich","wunder","wunderbar","wunderbaren","wunderschon","wutend","zeichen","zeitig","zen","zensiert","zerschlagen","zerschmetternd","zerstorend","zertifiziert","zielorientiert","zischend","zischt","zocken","zogernd","zugeben","zuruckgehalten","zuruckgelassen","zuruckweisen","zusatzlich","zutaten","zuverlassig","zwangsernahrt","zweifelnd","zwickend","zwingend","einfache","einfachen","einfaches","einfacher","simple","simplen","simples","simpler","besten","bestes","bester","beste","bestbewertet","bestbewerteten","bestbewertete","bestbewerteter","bestbewertetes","\u00fcberraschende","\u00fcberraschenden","\u00fcberraschendes","\u00fcberraschender","hilfreiche","hilfreiches","hilfreichen","hilfreicher","f\u00f6rdern","unterst\u00fctzen","helfen","spielerisch","spannende","spannendes","spannenden","spannender","gro\u00dfartige","gro\u00dfartiges","gro\u00dfartigen","gro\u00dfartiger","ideal","ideales","idealen","idealer","faszinierend","faszinierendes","faszinierenden","faszinierender","wichtig","wichtige","wichtiges","wichtigen","wichtiger","sicher","sichere","sicheres","sicheren","sicherer","umfassende","umfassendes","umfassenden","umfassender","ultimative","ultimatives","ultimativen","ultimativer","einzigartige","einzigartiges","einzigartigen","einzigartiger"],"diacritics":{"A":"[\\u0041\\u24B6\\uFF21\\u00C0\\u00C1\\u00C2\\u1EA6\\u1EA4\\u1EAA\\u1EA8\\u00C3\\u0100\\u0102\\u1EB0\\u1EAE\\u1EB4\\u1EB2\\u0226\\u01E0\\u01DE\\u1EA2\\u00C5\\u01FA\\u01CD\\u0200\\u0202\\u1EA0\\u1EAC\\u1EB6\\u1E00\\u0104\\u023A\\u2C6F]","AA":"[\\uA732]","AE":"[\\u00C6\\u01FC\\u01E2\\u00C4]","AO":"[\\uA734]","AU":"[\\uA736]","AV":"[\\uA738\\uA73A]","AY":"[\\uA73C]","B":"[\\u0042\\u24B7\\uFF22\\u1E02\\u1E04\\u1E06\\u0243\\u0182\\u0181]","C":"[\\u0043\\u24B8\\uFF23\\u0106\\u0108\\u010A\\u010C\\u00C7\\u1E08\\u0187\\u023B\\uA73E]","D":"[\\u0044\\u24B9\\uFF24\\u1E0A\\u010E\\u1E0C\\u1E10\\u1E12\\u1E0E\\u0110\\u018B\\u018A\\u0189\\uA779]","DZ":"[\\u01F1\\u01C4]","Dz":"[\\u01F2\\u01C5]","E":"[\\u0045\\u24BA\\uFF25\\u00C8\\u00C9\\u00CA\\u1EC0\\u1EBE\\u1EC4\\u1EC2\\u1EBC\\u0112\\u1E14\\u1E16\\u0114\\u0116\\u00CB\\u1EBA\\u011A\\u0204\\u0206\\u1EB8\\u1EC6\\u0228\\u1E1C\\u0118\\u1E18\\u1E1A\\u0190\\u018E]","F":"[\\u0046\\u24BB\\uFF26\\u1E1E\\u0191\\uA77B]","G":"[\\u0047\\u24BC\\uFF27\\u01F4\\u011C\\u1E20\\u011E\\u0120\\u01E6\\u0122\\u01E4\\u0193\\uA7A0\\uA77D\\uA77E]","H":"[\\u0048\\u24BD\\uFF28\\u0124\\u1E22\\u1E26\\u021E\\u1E24\\u1E28\\u1E2A\\u0126\\u2C67\\u2C75\\uA78D]","I":"[\\u0049\\u24BE\\uFF29\\u00CC\\u00CD\\u00CE\\u0128\\u012A\\u012C\\u0130\\u00CF\\u1E2E\\u1EC8\\u01CF\\u0208\\u020A\\u1ECA\\u012E\\u1E2C\\u0197]","J":"[\\u004A\\u24BF\\uFF2A\\u0134\\u0248]","K":"[\\u004B\\u24C0\\uFF2B\\u1E30\\u01E8\\u1E32\\u0136\\u1E34\\u0198\\u2C69\\uA740\\uA742\\uA744\\uA7A2]","L":"[\\u004C\\u24C1\\uFF2C\\u013F\\u0139\\u013D\\u1E36\\u1E38\\u013B\\u1E3C\\u1E3A\\u0141\\u023D\\u2C62\\u2C60\\uA748\\uA746\\uA780]","LJ":"[\\u01C7]","Lj":"[\\u01C8]","M":"[\\u004D\\u24C2\\uFF2D\\u1E3E\\u1E40\\u1E42\\u2C6E\\u019C]","N":"[\\u004E\\u24C3\\uFF2E\\u01F8\\u0143\\u00D1\\u1E44\\u0147\\u1E46\\u0145\\u1E4A\\u1E48\\u0220\\u019D\\uA790\\uA7A4]","NJ":"[\\u01CA]","Nj":"[\\u01CB]","O":"[\\u004F\\u24C4\\uFF2F\\u00D2\\u00D3\\u00D4\\u1ED2\\u1ED0\\u1ED6\\u1ED4\\u00D5\\u1E4C\\u022C\\u1E4E\\u014C\\u1E50\\u1E52\\u014E\\u022E\\u0230\\u022A\\u1ECE\\u0150\\u01D1\\u020C\\u020E\\u01A0\\u1EDC\\u1EDA\\u1EE0\\u1EDE\\u1EE2\\u1ECC\\u1ED8\\u01EA\\u01EC\\u00D8\\u01FE\\u0186\\u019F\\uA74A\\uA74C]","OE":"[\\u00D6]","OI":"[\\u01A2]","OO":"[\\uA74E]","OU":"[\\u0222]","P":"[\\u0050\\u24C5\\uFF30\\u1E54\\u1E56\\u01A4\\u2C63\\uA750\\uA752\\uA754]","Q":"[\\u0051\\u24C6\\uFF31\\uA756\\uA758\\u024A]","R":"[\\u0052\\u24C7\\uFF32\\u0154\\u1E58\\u0158\\u0210\\u0212\\u1E5A\\u1E5C\\u0156\\u1E5E\\u024C\\u2C64\\uA75A\\uA7A6\\uA782]","S":"[\\u0053\\u24C8\\uFF33\\u1E9E\\u015A\\u1E64\\u015C\\u1E60\\u0160\\u1E66\\u1E62\\u1E68\\u0218\\u015E\\u2C7E\\uA7A8\\uA784]","T":"[\\u0054\\u24C9\\uFF34\\u1E6A\\u0164\\u1E6C\\u021A\\u0162\\u1E70\\u1E6E\\u0166\\u01AC\\u01AE\\u023E\\uA786]","TZ":"[\\uA728]","U":"[\\u0055\\u24CA\\uFF35\\u00D9\\u00DA\\u00DB\\u0168\\u1E78\\u016A\\u1E7A\\u016C\\u01DB\\u01D7\\u01D5\\u01D9\\u1EE6\\u016E\\u0170\\u01D3\\u0214\\u0216\\u01AF\\u1EEA\\u1EE8\\u1EEE\\u1EEC\\u1EF0\\u1EE4\\u1E72\\u0172\\u1E76\\u1E74\\u0244]","UE":"[\\u00DC]","V":"[\\u0056\\u24CB\\uFF36\\u1E7C\\u1E7E\\u01B2\\uA75E\\u0245]","VY":"[\\uA760]","W":"[\\u0057\\u24CC\\uFF37\\u1E80\\u1E82\\u0174\\u1E86\\u1E84\\u1E88\\u2C72]","X":"[\\u0058\\u24CD\\uFF38\\u1E8A\\u1E8C]","Y":"[\\u0059\\u24CE\\uFF39\\u1EF2\\u00DD\\u0176\\u1EF8\\u0232\\u1E8E\\u0178\\u1EF6\\u1EF4\\u01B3\\u024E\\u1EFE]","Z":"[\\u005A\\u24CF\\uFF3A\\u0179\\u1E90\\u017B\\u017D\\u1E92\\u1E94\\u01B5\\u0224\\u2C7F\\u2C6B\\uA762]","a":"[\\u0061\\u24D0\\uFF41\\u1E9A\\u00E0\\u00E1\\u00E2\\u1EA7\\u1EA5\\u1EAB\\u1EA9\\u00E3\\u0101\\u0103\\u1EB1\\u1EAF\\u1EB5\\u1EB3\\u0227\\u01E1\\u01DF\\u1EA3\\u00E5\\u01FB\\u01CE\\u0201\\u0203\\u1EA1\\u1EAD\\u1EB7\\u1E01\\u0105\\u2C65\\u0250]","aa":"[\\uA733]","ae":"[\\u00E6\\u01FD\\u01E3\\u00E4]","ao":"[\\uA735]","au":"[\\uA737]","av":"[\\uA739\\uA73B]","ay":"[\\uA73D]","b":"[\\u0062\\u24D1\\uFF42\\u1E03\\u1E05\\u1E07\\u0180\\u0183\\u0253]","c":"[\\u0063\\u24D2\\uFF43\\u0107\\u0109\\u010B\\u010D\\u00E7\\u1E09\\u0188\\u023C\\uA73F\\u2184]","d":"[\\u0064\\u24D3\\uFF44\\u1E0B\\u010F\\u1E0D\\u1E11\\u1E13\\u1E0F\\u0111\\u018C\\u0256\\u0257\\uA77A]","dz":"[\\u01F3\\u01C6]","e":"[\\u0065\\u24D4\\uFF45\\u00E8\\u00E9\\u00EA\\u1EC1\\u1EBF\\u1EC5\\u1EC3\\u1EBD\\u0113\\u1E15\\u1E17\\u0115\\u0117\\u00EB\\u1EBB\\u011B\\u0205\\u0207\\u1EB9\\u1EC7\\u0229\\u1E1D\\u0119\\u1E19\\u1E1B\\u0247\\u025B\\u01DD]","f":"[\\u0066\\u24D5\\uFF46\\u1E1F\\u0192\\uA77C]","g":"[\\u0067\\u24D6\\uFF47\\u01F5\\u011D\\u1E21\\u011F\\u0121\\u01E7\\u0123\\u01E5\\u0260\\uA7A1\\u1D79\\uA77F]","h":"[\\u0068\\u24D7\\uFF48\\u0125\\u1E23\\u1E27\\u021F\\u1E25\\u1E29\\u1E2B\\u1E96\\u0127\\u2C68\\u2C76\\u0265]","hv":"[\\u0195]","i":"[\\u0069\\u24D8\\uFF49\\u00EC\\u00ED\\u00EE\\u0129\\u012B\\u012D\\u00EF\\u1E2F\\u1EC9\\u01D0\\u0209\\u020B\\u1ECB\\u012F\\u1E2D\\u0268\\u0131]","j":"[\\u006A\\u24D9\\uFF4A\\u0135\\u01F0\\u0249]","k":"[\\u006B\\u24DA\\uFF4B\\u1E31\\u01E9\\u1E33\\u0137\\u1E35\\u0199\\u2C6A\\uA741\\uA743\\uA745\\uA7A3]","l":"[\\u006C\\u24DB\\uFF4C\\u0140\\u013A\\u013E\\u1E37\\u1E39\\u013C\\u1E3D\\u1E3B\\u017F\\u0142\\u019A\\u026B\\u2C61\\uA749\\uA781\\uA747]","lj":"[\\u01C9]","m":"[\\u006D\\u24DC\\uFF4D\\u1E3F\\u1E41\\u1E43\\u0271\\u026F]","n":"[\\u006E\\u24DD\\uFF4E\\u01F9\\u0144\\u00F1\\u1E45\\u0148\\u1E47\\u0146\\u1E4B\\u1E49\\u019E\\u0272\\u0149\\uA791\\uA7A5]","nj":"[\\u01CC]","o":"[\\u006F\\u24DE\\uFF4F\\u00F2\\u00F3\\u00F4\\u1ED3\\u1ED1\\u1ED7\\u1ED5\\u00F5\\u1E4D\\u022D\\u1E4F\\u014D\\u1E51\\u1E53\\u014F\\u022F\\u0231\\u022B\\u1ECF\\u0151\\u01D2\\u020D\\u020F\\u01A1\\u1EDD\\u1EDB\\u1EE1\\u1EDF\\u1EE3\\u1ECD\\u1ED9\\u01EB\\u01ED\\u00F8\\u01FF\\u0254\\uA74B\\uA74D\\u0275]","oe":"[\\u00f6]","oi":"[\\u01A3]","ou":"[\\u0223]","oo":"[\\uA74F]","p":"[\\u0070\\u24DF\\uFF50\\u1E55\\u1E57\\u01A5\\u1D7D\\uA751\\uA753\\uA755]","q":"[\\u0071\\u24E0\\uFF51\\u024B\\uA757\\uA759]","r":"[\\u0072\\u24E1\\uFF52\\u0155\\u1E59\\u0159\\u0211\\u0213\\u1E5B\\u1E5D\\u0157\\u1E5F\\u024D\\u027D\\uA75B\\uA7A7\\uA783]","s":"[\\u0073\\u24E2\\uFF53\\u015B\\u1E65\\u015D\\u1E61\\u0161\\u1E67\\u1E63\\u1E69\\u0219\\u015F\\u023F\\uA7A9\\uA785\\u1E9B]","ss":"[\\u00DF]","t":"[\\u0074\\u24E3\\uFF54\\u1E6B\\u1E97\\u0165\\u1E6D\\u021B\\u0163\\u1E71\\u1E6F\\u0167\\u01AD\\u0288\\u2C66\\uA787]","tz":"[\\uA729]","u":"[\\u0075\\u24E4\\uFF55\\u00F9\\u00FA\\u00FB\\u0169\\u1E79\\u016B\\u1E7B\\u016D\\u01DC\\u01D8\\u01D6\\u01DA\\u1EE7\\u016F\\u0171\\u01D4\\u0215\\u0217\\u01B0\\u1EEB\\u1EE9\\u1EEF\\u1EED\\u1EF1\\u1EE5\\u1E73\\u0173\\u1E77\\u1E75\\u0289]","ue":"[\\u00FC]","v":"[\\u0076\\u24E5\\uFF56\\u1E7D\\u1E7F\\u028B\\uA75F\\u028C]","vy":"[\\uA761]","w":"[\\u0077\\u24E6\\uFF57\\u1E81\\u1E83\\u0175\\u1E87\\u1E85\\u1E98\\u1E89\\u2C73]","x":"[\\u0078\\u24E7\\uFF58\\u1E8B\\u1E8D]","y":"[\\u0079\\u24E8\\uFF59\\u1EF3\\u00FD\\u0177\\u1EF9\\u0233\\u1E8F\\u00FF\\u1EF7\\u1E99\\u1EF5\\u01B4\\u024F\\u1EFF]","z":"[\\u007A\\u24E9\\uFF5A\\u017A\\u1E91\\u017C\\u017E\\u1E93\\u1E95\\u01B6\\u0225\\u0240\\u2C6C\\uA763]"},"researchesTests":["contentHasTOC","contentHasShortParagraphs","contentHasAssets","keywordInTitle","keywordInMetaDescription","keywordInPermalink","keywordIn10Percent","keywordInContent","keywordInSubheadings","keywordInImageAlt","keywordDensity","keywordNotUsed","lengthContent","lengthPermalink","linksHasInternal","linksHasExternals","linksNotAllExternals","titleStartWithKeyword","titleSentiment","titleHasPowerWords","titleHasNumber","hasContentAI"],"hasRedirection":false,"hasBreadcrumb":false},"homeUrl":"https:\/\/www.bvimedical.com\/de","objectID":1591,"objectType":"post","locale":"de","localeFull":"de_DE","overlayImages":{"play":{"name":"Wiedergabezeichen","url":"https:\/\/www.bvimedical.com\/de\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/icon-play.png","path":"\/nas\/content\/live\/bvi\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/icon-play.png","position":"middle_center"},"gif":{"name":"GIF-Symbol","url":"https:\/\/www.bvimedical.com\/de\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/icon-gif.png","path":"\/nas\/content\/live\/bvi\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/icon-gif.png","position":"middle_center"}},"defautOgImage":"https:\/\/www.bvimedical.com\/de\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/social-placeholder.jpg","customPermalinks":true,"isUserRegistered":false,"autoSuggestKeywords":false,"connectSiteUrl":"https:\/\/rankmath.com\/auth?site=https%3A%2F%2Fwww.bvimedical.com%2Fde&r=https%3A%2F%2Fwww.bvimedical.com%2Fde%2Fwp-json%2Fwp%2Fv2%2Fpages%2F1591%3Fnonce%3Dee6e32a9ad","maxTags":5,"trendsIcon":"